Sanofi India

SANOFI29 Apr 2024

Pharmaceuticals

₹

+81.30 (+0.98%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Sanofi India

Sanofi India

Pharmaceuticals

SANOFI29 Apr 2024

₹

+81.30 (+0.98%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
23-Feb-2024	D	The Board, at its meeting held on 23rd February, 2024, has declared an Interim Dividend of Rs. 50 per equity share and recommended a Final Dividend of Rs. 117 per equity share. Kindly refer the attachment for further details on payment date. The Record date for the Interim Dividend shall be 7th March, 2024 and for the Final Dividend shall be 3rd May, 2024. Please note that the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 4th May 2024 to Tuesday, 14th May 2024 (both days inclusive) for the purpose of payment of final dividend for the year ended 31st December 2023. Accordingly, the record date for the payment shall be Friday, 3rd May 2024. (As per BSE Announcement Dated on 22/03/2024)	03-May-2024
23-Feb-2024	D	The Board, at its meeting held on 23rd February, 2024, has declared an Interim Dividend of Rs. 50 per equity share and recommended a Final Dividend of Rs. 117 per equity share. Kindly refer the attachment for further details on payment date. The Record date for the Interim Dividend shall be 7th March, 2024 and for the Final Dividend shall be 3rd May, 2024.	07-Mar-2024
23-Feb-2023	D	1. Recommended a final dividend of Rs. 194/- per equity share of the face value of Rs.10/- each and a second special dividend of Rs. 183/- per equity share of the face value of Rs.10/- each for the financial year ended 31st December 2022, subject to approval by the Shareholders at the 67th Annual General Meeting. The Company had earlier paid one-time special interim dividend of Rs. 193/- per equity share on 22nd August 2022. 2. The total dividend for the financial year 2022, including the proposed final dividend, one-time special interim dividend and second special dividend, amounts to Rs. 570/- per equity share of the face value of Rs.10/- each. The Dividend, if approved by the Shareholders will be paid on or after 22nd May 2023;	28-Apr-2023
23-Feb-2023	D	1. Recommended a final dividend of Rs. 194/- per equity share of the face value of Rs.10/- each and a second special dividend of Rs. 183/- per equity share of the face value of Rs.10/- each for the financial year ended 31st December 2022, subject to approval by the Shareholders at the 67th Annual General Meeting. The Company had earlier paid one-time special interim dividend of Rs. 193/- per equity share on 22nd August 2022. 2. The total dividend for the financial year 2022, including the proposed final dividend, one-time special interim dividend and second special dividend, amounts to Rs. 570/- per equity share of the face value of Rs.10/- each. The Dividend, if approved by the Shareholders will be paid on or after 22nd May 2023.	28-Apr-2023
26-Jul-2022	D	Dear Sirs, The Board of Directors of the Company at its Meeting held today has declared One-Time Special Interim Dividend of Rs. 193 per equity share of Rs. 10 each for the financial year ending 31st December 2022. The Meeting of Board of Directors commenced at 2.00 p.m. and concluded at 5.10 p.m. As informed earlier the Company has fixed 8th August 2022 as the record date for the purpose of payment of the One-Time Special Interim Dividend. The said dividend will be paid on or after 22nd August 2022.	05-Aug-2022
23-Feb-2022	D	Recommendation for payment of a final dividend of Rs.181 per equity share of Rs. 10 each for the year ended 31st December 2021 and a special dividend of Rs. 309 per equity share of Rs.10 each for the year ended 31st December 2021, after considering the slump sale and transfer of Company's nutraceuticals business during the year and reviewing the cash requirements for the Company's operations.	12-Apr-2022
23-Feb-2022	D	Recommendation for payment of a final dividend of Rs.181 per equity share of Rs. 10 each for the year ended 31st December 2021 and a special dividend of Rs. 309 per equity share of Rs.10 each for the year ended 31st December 2021, after considering the slump sale and transfer of Company's nutraceuticals business during the year and reviewing the cash requirements for the Company's operations.	12-Apr-2022
23-Feb-2021	D	The following items were considered and approved: 1. Recommendation for payment of a final dividend of Rs.125 per equity share of Rs. 10 each for the year ended 31 st December 2020 and a special dividend of Rs. 240 per equity share of Rs.10 each for the year ended 31 st December 2020, after considering the closure of the slump sale transaction relating to Ankleshwar Manufacturing facility and reviewing the cash requirements for the Company's operations. 2. Closure of Register of Members and Share Transfer Books from 21 st April 2021 to 27th April 2021 (both days inclusive) for determining the eligibility of shareholders for payment of the finaldividend and the special dividend. 3. Holding of the Annual General Meeting (AGM) of the Company on 27th April 2021 through video conferencing mode. Further details of the AGM will be provided in the notice of the AGM which will be issued in due course. 4. The final dividend and the special dividend, if approved by the shareholders will be paid on or after 4th May 2021 (As per BSE Bulletin Dated on 23/2/2021)	19-Apr-2021
23-Feb-2021	D	The following items were considered and approved: 1. Recommendation for payment of a final dividend of Rs.125 per equity share of Rs. 10 each for the year ended 31 st December 2020 and a special dividend of Rs. 240 per equity share of Rs.10 each for the year ended 31 st December 2020, after considering the closure of the slump sale transaction relating to Ankleshwar Manufacturing facility and reviewing the cash requirements for the Company's operations. 2. Closure of Register of Members and Share Transfer Books from 21 st April 2021 to 27th April 2021 (both days inclusive) for determining the eligibility of shareholders for payment of the finaldividend and the special dividend. 3. Holding of the Annual General Meeting (AGM) of the Company on 27th April 2021 through video conferencing mode. Further details of the AGM will be provided in the notice of the AGM which will be issued in due course. 4. The final dividend and the special dividend, if approved by the shareholders will be paid on or after 4th May 2021	19-Apr-2021
25-Feb-2020	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2020, inter alia, has considered and approved the following : 1. Recommendation for payment of final dividend of Rs. 106 per equity share Rs. 10 each and one-time special dividend of Rs. 243 per equity share Rs. 10 each for the year ended December 31, 2019. The total dividend recommended is Rs. 349 per equity share Rs. 10 each for the year ended December 31, 2019.	29-Jun-2020
25-Feb-2020	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2020, inter alia, has considered and approved the following : 1. Recommendation for payment of final dividend of Rs. 106 per equity share Rs. 10 each and one-time special dividend of Rs. 243 per equity share Rs. 10 each for the year ended December 31, 2019. The total dividend recommended is Rs. 349 per equity share Rs. 10 each for the year ended December 31, 2019. 2. The final as well as one-time special dividend, if approved by the shareholders will be paid on or after May 05, 2020.	29-Jun-2020
26-Feb-2019	D	We refer to our letter dated 11th February 2019 informing you of our Board Meeting that was scheduled today. The Meeting of Board of Directors commenced at 12.00 noon and concluded at 04.30 p.m. The following items were considered and approved: Recommendation for payment of final dividend of Rs.66 per equity share of Rs. 10 each for the year ended 31st December 2018. Convening of the AGM of the Company on Tuesday, 7th May 2019. Closure of Register of Members and Share Transfer Books from 30th April 2019 to 7th May 2019 (both days inclusive) for determining the eligibility of shareholders for payment of final dividend and AGM. The final dividend, if approved by the shareholders shall be payable on or after 14th May 2019. Please take the above information on record.	25-Apr-2019
25-Jul-2018	D	The Board of Directors of the Company at its Meeting held today has declared an Interim Dividend of Rs. 18 per equity share of Rs. 10 each for the financial year ending 31st December 2018. The Meeting of Board of Directors commenced at 2.30 p.m. and concluded at 5.20 p.m. The Company has fixed 7th August 2018 as the record date for the purpose of payment of the Interim Dividend. The said dividend will be paid on or after 14th August 2018.	06-Aug-2018
22-Feb-2018	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 22, 2018, inter alia, has recommended a final dividend of Rs. 53 per equity share of Rs. 10 for the year ended December 31, 2017. An interim dividend of Rs.18 per equity share of Rs.10 was paid in August 2017. The interim dividend and the proposed final dividend totalling to Rs 71 per equity share of Rs 10, will together amount to a distribution of Rs.1,633 million (excluding dividend distribution tax).	26-Apr-2018
19-Jul-2017	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 19, 2017, has declared an Interim Dividend of Rs. 18 per equity share of Rs. 10 each for the financial year ending December 31, 2017.	31-Jul-2017
27-Feb-2017	D	Sanofi India Ltd has informed BSE that the Board Meeting that was scheduled on February 27, 2017. The following items were considered and approved: - Dividend recommendation of Rs. 50 per equity share of Rs. 10 each for the year ended December 31, 2016.	25-Apr-2017
22-Jul-2016	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 22, 2016, inter alia, has declared an Interim Dividend of Rs. 18 per Equity share of Rs. 10 each.	04-Aug-2016
04-Feb-2016	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 04, 2016, inter alia, has recommended: 1. Final dividend of Rs. 25 per Equity share of Rs. 10 for the year ended December 31, 2015. An Interim dividend of Rs. 18 per Equity Share of Rs. 10 had been paid in August 2015.	13-Apr-2016
04-Feb-2016	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 04, 2016, inter alia, has recommended: A Special One-time dividend of Rs. 14 per Equity share of Rs.10 arising from the profit on the sale of the Company's commercial premises in Mumbai.	13-Apr-2016
04-Feb-2016	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 04, 2016, inter alia, has recommended: A Special One-time Diamond Jubilee dividend of Rs. 8 per Equity share of Rs. 10 as the Company will complete sixty years from its incorporation on May 02, 1956.	13-Apr-2016
21-Jul-2015	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 21, 2015, inter alia, has declared an Interim Dividend of Rs. 18 (Rupees Eighteen only) per Equity Share of Rs. 10 for the financial year ending December 31, 2015. The Interim Dividend will be paid on August 12, 2015.	29-Jul-2015
20-Feb-2015	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 20, 2015, inter alia, has recommended: a) Final dividend of Rs. 24 per Equity share of Rs. 10 for the year ended December 31, 2014. An Interim dividend of Rs. 10 per Equity share of Rs. 10 had been paid in August 2014.	16-Apr-2015
20-Feb-2015	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 20, 2015, inter alia, has recommended: a) A Special One-time dividend of Rs. 11 per Equity shares of Rs. 10 arising from the profit on the sale of the Company's commercial premises in Mumbai. The Interim dividend, proposed Final dividend and Special One-time dividend will together amount to a distribution of Rs. 1036 million (excluding Dividend Distribution tax).	16-Apr-2015
23-Jul-2014	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 23, 2014, inter alia, has declared an Interim Dividend of Rs. 10 (Rupees Ten Only) per Equity Share of Rs. 10 for the financial year ending December 31, 2014. The Interim Dividend will be paid on August 14, 2014.	31-Jul-2014
25-Feb-2014	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2014, inter alia, has recommended Final dividend of Rs. 35 per Equity Shares of Rs. 10 for the year ended December 31, 2013.	16-Apr-2014
30-Jul-2013	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 30, 2013, inter alia, has declared an Interim Dividend of Rs. 10 per Equity share of Rs. 10. The said dividend will be paid on August 20, 2013.	05-Aug-2013
25-Feb-2013	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 25, 2013, inter alia, has recommended Final dividend of Rs. 29 per Equity share of Rs. 10 for the year ended December 31, 2012.	05-Apr-2013
25-Jul-2012	D	Sanofi India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 25, 2012, inter alia, has declared an Interim Dividend of Rs. 4 (Rupees Four only) per Equity Share of Rs. 10 for the financial year ending December 31, 2012. The Interim Dividend will be paid on August 16, 2012.	02-Aug-2012
23-Feb-2012	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 23, 2012, inter alia, has recommended Final Dividend of Rs. 29 per Equity share of Rs. 10 for the year ended December 31, 2011.	10-Apr-2012
28-Jul-2011	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 28, 2011, inter alia, has declared an Interim Dividend of Rs. 4 (Rupees Four only) per Equity Share of Rs. 10 for the financial year ending December 31, 2011.	03-Aug-2011
16-Feb-2011	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 16, 2011, inter alia, has recommended: 1. Final Dividend of Rs. 23 per Equity share of Rs. 10 for the year ended December 31, 2010. An Interim dividend of Rs. 4 per Equity share of Rs. 10 had been paid in August 2010.	31-Mar-2011
16-Feb-2011	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 16, 2011, inter alia, has recommended: A Special One-time Dividend of Rs. 28 per Equity share of Rs. 10 arising from the profit of the sale of the Company's shareholding in Chiron Behring Vaccines Private Limited. The Special One-time Dividend (excluding Dividend Distribution tax) constitutes a distribution of 85.14% of the Profit after tax arising from the said sale of shareholding.	31-Mar-2011
19-Jul-2010	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 19, 2010, inter alia, has declared an Interim Dividend of Rs. 4 per Equity Share of Rs. 10.	26-Jul-2010
24-Feb-2010	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 24, 2010, inter alia, has recommended a Final dividend of Rs. 16.50 per Equity share of Rs. 10 for the year ended December 31, 2009. An interim dividend of Rs. 3.50 per Equity share of Rs. 10 had been paid in August 2009. The total dividend for the year ended December 31, 2009 is accordingly Rs. 20 per equity share of Rs. 10 (Previous year: Rs. 16 per Equity share). The dividend payout is 29.3% of the Net Profit for the year ended December 31, 2009.	07-Apr-2010
22-Jul-2009	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 22, 2009, inter alia, has declared an interim dividend of Rs 3.50 per Equity share of Rs 10 for the financial year ending December 31, 2009.	30-Jul-2009
17-Feb-2009	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 17, 2009, inter alia, has recommended a Final dividend of Rs 12.50 per Equity share of Rs 10 for the year ended December 31, 2008. An Interim dividend of Rs 3.50 per Equity share of Rs 10 had been paid in August 2008.	06-Apr-2009
24-Jul-2008	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 24, 2008, inter alia, has declared an Interim dividend of Rs 3.50 per Equity share of Rs 10 each of the Company.	29-Jul-2008
21-Feb-2008	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at is meeting held on February 21, 2008, inter alia, has recommended a Final dividend of Rs 12.50 per Equity share of Rs 10 for the year ended December 31, 2007. An interim dividend of Rs 3.50 per Equity share of Rs 10 had been paid in August 2007.	03-Apr-2008
17-Jul-2007	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on July 17, 2007, inter alia, has declared an Interim Dividend of Rs 3.50 per Equity Share of Rs 10 for the financial year ending December 31, 2007.	25-Jul-2007
16-Mar-2007	D	Aventis Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on March 16, 2007 has declared a Second Interim Dividend of Rs 28.50 per Equity Share of Rs 10 ( which is inclusive of a Special One-time Golden Jubilee Dividend of Rs 16.00 per Equity share) for the financial year ended December 31, 2006.	22-Mar-2007
26-Jul-2006	D	35% Interim Dividend	03-Aug-2006
23-Mar-2006	D	125% Dividend	19-May-2006
01-Aug-2005	D	35% Interim Dividend	03-Aug-2005
31-Aug-2004	D		07-May-2004
30-Jun-2003	D	The Board has declared an Interim Dividend of Rs 3.50 per share	07-Aug-2003
23-Feb-2024	BC	We enclose a copy of the Auditor''s report and Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ended 31st December 2023 along with Statement of Assets and	14-May-2024
26-Apr-2024	BC	Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024 inter alia to consider and approve the Unaudited Financial Statements (Standalone	13-May-2024
22-Mar-2024	BC	Please note that the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 4th May 2024 to Tuesday, 14th May 2024 (both days inclusive) for the purpose of paym	04-May-2024
23-Feb-2024	BC	The Record date for the Interim Dividend shall be 7th March, 2024 and for the Final Dividend shall be 3rd May, 2024.	03-May-2024
26-Mar-2024	BC	1170% Final Dividend	03-May-2024

Announcement Date23-Feb-2024

Ex Dividend Date03-May-2024

Dividend(%)1170

Announcement Date23-Feb-2024

Ex Dividend Date07-Mar-2024

Dividend(%)500

Announcement Date23-Feb-2023

Ex Dividend Date28-Apr-2023

Dividend(%)1940

Announcement Date23-Feb-2023

Ex Dividend Date28-Apr-2023

Dividend(%)1830

Announcement Date26-Jul-2022

Ex Dividend Date05-Aug-2022

Dividend(%)1930

Announcement Date23-Feb-2022

Ex Dividend Date12-Apr-2022

Dividend(%)1810

Announcement Date23-Feb-2022

Ex Dividend Date12-Apr-2022

Dividend(%)3090

Announcement Date23-Feb-2021

Ex Dividend Date19-Apr-2021

Dividend(%)1250

Announcement Date23-Feb-2021

Ex Dividend Date19-Apr-2021

Dividend(%)2400

Announcement Date25-Feb-2020

Ex Dividend Date29-Jun-2020

Dividend(%)1060

Announcement Date25-Feb-2020

Ex Dividend Date29-Jun-2020

Dividend(%)2430

Announcement Date26-Feb-2019

Ex Dividend Date25-Apr-2019

Dividend(%)660

Announcement Date25-Jul-2018

Ex Dividend Date06-Aug-2018

Dividend(%)180

Announcement Date22-Feb-2018

Ex Dividend Date26-Apr-2018

Dividend(%)530

Announcement Date19-Jul-2017

Ex Dividend Date31-Jul-2017

Dividend(%)180

Announcement Date27-Feb-2017

Ex Dividend Date25-Apr-2017

Dividend(%)500

Announcement Date22-Jul-2016

Ex Dividend Date04-Aug-2016

Dividend(%)180

Announcement Date04-Feb-2016

Ex Dividend Date13-Apr-2016

Dividend(%)250

Announcement Date04-Feb-2016

Ex Dividend Date13-Apr-2016

Dividend(%)140

Announcement Date04-Feb-2016

Ex Dividend Date13-Apr-2016

Dividend(%)80

Announcement Date21-Jul-2015

Ex Dividend Date29-Jul-2015

Dividend(%)180

Announcement Date20-Feb-2015

Ex Dividend Date16-Apr-2015

Dividend(%)240

Announcement Date20-Feb-2015

Ex Dividend Date16-Apr-2015

Dividend(%)110

Announcement Date23-Jul-2014

Ex Dividend Date31-Jul-2014

Dividend(%)100

Announcement Date25-Feb-2014

Ex Dividend Date16-Apr-2014

Dividend(%)350

Announcement Date30-Jul-2013

Ex Dividend Date05-Aug-2013

Dividend(%)100

Announcement Date25-Feb-2013

Ex Dividend Date05-Apr-2013

Dividend(%)290

Announcement Date25-Jul-2012

Ex Dividend Date02-Aug-2012

Dividend(%)40

Announcement Date23-Feb-2012

Ex Dividend Date10-Apr-2012

Dividend(%)290

Announcement Date28-Jul-2011

Ex Dividend Date03-Aug-2011

Dividend(%)40

Announcement Date16-Feb-2011

Ex Dividend Date31-Mar-2011

Dividend(%)230

Announcement Date16-Feb-2011

Ex Dividend Date31-Mar-2011

Dividend(%)280

Announcement Date19-Jul-2010

Ex Dividend Date26-Jul-2010

Dividend(%)40

Announcement Date24-Feb-2010

Ex Dividend Date07-Apr-2010

Dividend(%)165

Announcement Date22-Jul-2009

Ex Dividend Date30-Jul-2009

Dividend(%)35

Announcement Date17-Feb-2009

Ex Dividend Date06-Apr-2009

Dividend(%)125

Announcement Date24-Jul-2008

Ex Dividend Date29-Jul-2008

Dividend(%)35

Announcement Date21-Feb-2008

Ex Dividend Date03-Apr-2008

Dividend(%)125

Announcement Date17-Jul-2007

Ex Dividend Date25-Jul-2007

Dividend(%)35

Announcement Date16-Mar-2007

Ex Dividend Date22-Mar-2007

Dividend(%)125

Announcement Date26-Jul-2006

Ex Dividend Date03-Aug-2006

Dividend(%)35

Announcement Date23-Mar-2006

Ex Dividend Date19-May-2006

Dividend(%)125

Announcement Date01-Aug-2005

Ex Dividend Date03-Aug-2005

Dividend(%)35

Announcement Date31-Aug-2004

Ex Dividend Date07-May-2004

Dividend(%)125

Announcement Date30-Jun-2003

Ex Dividend Date07-Aug-2003

Dividend(%)35

No Rights has been declared by SANOFI

Book Closure

Record Date	Split Date	Purpose
14-May-2024	-	We enclose a copy of the Auditor''s report and Audited Standalone and Consolidated Financial Results of the Company for the Financial Year ended 31st December 2023 along with Statement of Assets and
13-May-2024	-	Sanofi India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/05/2024 inter alia to consider and approve the Unaudited Financial Statements (Standalone
04-May-2024	01 Jan'1900	Please note that the Register of Members and Share Transfer Books of the Company will remain closed from Saturday, 4th May 2024 to Tuesday, 14th May 2024 (both days inclusive) for the purpose of paym
03-May-2024	-	The Record date for the Interim Dividend shall be 7th March, 2024 and for the Final Dividend shall be 3rd May, 2024.
03-May-2024	-	1170% Final Dividend

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Sanofi India Ltd ₹8,359.40(+81.30/0.98%)	8,359.40	+81.30	19,064.46	38.51	32.28	18.77
Astrazeneca Pharma India Ltd ₹5,462.40(+47.00/0.87%)	5,462.40	+47.00	13,538.50	71.09	84.88	20.67
Bliss GVS Pharma Ltd ₹125.40(+2.80/2.28%)	125.40	+2.80	1,283.51	60.79	18.80	1.31
Cipla Ltd ₹1,402.85(-6.55/-0.46%)	1,402.85	-6.55	113,794.25	54.54	34.60	4.40
Abbott India Ltd ₹25,916.05(+51.20/0.20%)	25,916.05	+51.20	54,962.81	15.87	47.98	17.68
Amrutanjan Health Care Ltd ₹696.20(+15.35/2.25%)	696.20	+15.35	1,968.38	13.21	44.73	7.51

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	693.90	714.60	706.10	736.50	671.90	691.90
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	693.90	714.60	706.10	736.50	671.90	691.90
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	12.00	11.80	15.70	43.60	33.90	11.40
Total Income	705.90	726.40	721.80	780.10	705.80	703.30
Total Expenditure	506.50	506.10	527.90	506.60	505.00	510.00
PBIDT	199.40	220.30	193.90	273.50	200.80	193.30
Interest	0.40	0.30	0.70	0.30	0.40	0.50
PBDT	199.00	220.00	193.20	273.20	200.40	192.80
Depreciation	10.20	9.90	9.80	9.70	10.00	10.40
Tax	49.60	58.60	61.30	73.80	63.00	52.70
Deferred Tax	1.50	-0.70	-0.80	-0.70	-3.50	-1.20
Reported Profit After Tax	137.70	152.20	122.90	190.40	130.90	130.90
Extra-ordinary Items	0.00	0.00	0.00	12.81	9.30	0.00
Adjusted Profit After Extra-ordinary item	137.70	152.20	122.90	177.59	121.60	130.90

EPS (Unit Curr.)	59.79	66.08	53.37	82.67	56.84	56.84
EPS (Adj) (Unit Curr.)	59.79	66.08	53.37	82.67	56.84	56.84
Calculated EPS (Unit Curr.)	59.87	66.17	53.43	82.78	56.91	56.91
Calculated EPS (Adj) (Unit Curr.)	59.87	66.17	53.43	82.78	56.91	56.91
Calculated EPS (Ann.) (Unit Curr.)	239.48	264.70	213.74	331.13	227.65	227.65
Calculated EPS (Adj) (Ann.) (Unit Curr.)	239.48	264.70	213.74	331.13	227.65	227.65
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	23.00	23.00	23.00	23.00	23.00	23.00
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	28.74	30.83	27.46	37.14	29.89	27.94
PBDTM(%)	28.68	30.79	27.36	37.09	29.83	27.87
PATM(%)	19.84	21.30	17.41	25.85	19.48	18.92

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19	Dec 18
SOURCES OF FUNDS :
Share Capital	23.00	23.00	23.00	23.00	23.00	23.00
Reserves Total	992.50	1252.80	2202.60	2096.00	2419.30	2196.20
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	1015.50	1275.80	2225.60	2119.00	2442.30	2219.20
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	19.00	23.60	24.60	22.60	0.00	0.00
Total Debt	19.00	23.60	24.60	22.60	0.00	0.00
Total Liabilities	1034.50	1299.40	2250.20	2141.60	2442.30	2219.20
APPLICATION OF FUNDS :
Gross Block	543.60	530.90	546.30	851.70	817.10	1053.30
Less : Accumulated Depreciation	228.70	225.40	212.20	387.60	318.40	320.50
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	314.90	305.50	334.10	464.10	498.70	732.80
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	15.90	23.60	12.80	10.00	17.40	21.10
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	2.00	0.00	0.00	0.00	0.00	0.20
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	663.80	408.00	392.40	368.00	469.60	483.10
Sundry Debtors	131.70	129.10	142.90	148.00	224.00	158.40
Cash and Bank	404.90	1016.90	1550.30	1208.60	1129.50	831.90
Loans and Advances	45.90	56.30	52.30	108.70	306.20	118.80
Total Current Assets	1246.30	1610.30	2137.90	1833.30	2129.30	1592.20
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	410.60	499.20	505.90	443.50	506.70	454.10
Provisions	235.60	232.70	236.70	238.60	196.70	169.40
Total Current Liabilities	646.20	731.90	742.60	682.10	703.40	623.50
Net Current Assets	600.10	878.40	1395.30	1151.20	1425.90	968.70
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	37.40	40.80	44.60	43.00	40.60	36.90
Deferred Tax Liability	41.10	45.70	50.90	73.20	85.20	129.00
Net Deferred Tax	-3.70	-4.90	-6.30	-30.20	-44.60	-92.10
Total Assets	929.20	1202.60	1735.90	1595.10	1897.40	1630.70
Contingent Liabilities	290.90	269.40	278.10	264.50	274.50	213.50

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Dec 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019
Cash and Cash Equivalents at Beginning of the year	1004.90	1538.00	1197.40	1119.90	825.10
Net Cash from Operating Activities	230.80	398.70	558.80	611.10	412.30
Net Cash Used In Investing Activities	35.50	650.90	630.80	276.40	65.70
Net Cash Used In Financing Activities	-878.30	-1582.70	-849.00	-810.00	-183.20
Net Inc./Dec In Cash And Cash Equivalents	-612.00	-533.10	340.60	77.50	294.80
Cash And Cash Equivalents At End Of The Year	392.90	1004.90	1538.00	1197.40	1119.90

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

60.40%

FII Shareholding

6.11%

DII Shareholding

23.08%

Public Shareholding

10.41%

**Promoter pledged shareholding 60.40%

About Sanofi India Ltd

Sanofi India Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 19064.46 crores. It has reported a sales of Rs. 693.9 crores and a net profit of Rs. 137.7 crores for the quarter ended December 2018. The company management includes Aditya Narayan, Aditya Narayan,Usha Thorat,Vaibhav KARANDIKAR,Rahul Bhatnagar,Marc-Antoine Lucchini,Annapurna Das,Rodolfo Hrosz,Radhika Shah,Renee Amonkar (Sanofi India Ltd) among others.

Chairman

Aditya Narayan

Registered office

Sanofi Hse 117-B Saki Vihar Rd,L&T Business Park Powai,Mumbai,Maharashtra,400072

FAX :91-22-28032939

Background

Incorporation Year1956

Face Value₹10

Market Lot1

How to buy Sanofi India shares on nse?

To buy Sanofi India shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Sanofi India share price today?

The Sanofi India shares price on nse is Rs.8363.75 today.

What is the market cap of Sanofi India shares on BSE ?

The company has a market capitalization of Rs.19064.46Cr

What is the PE & PB ratio of Sanofi India shares ?

PE is 32.28 and PB is 18.77

What is the 52 Week High and Low of Sanofi India shares?

Sanofi India stock price high: Rs.9370.35 Sanofi India stock price low: Rs.5329.7